Sudden cardiac death echocardiography and ultrasound

	Sudden cardiac death Microchapters
Home
Patient Information
Sudden Cardiac versus Non-Cardiac Death
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Definitions and Diagnosis
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Urgent Treatment
Post Arrest Care and Prevention
Ethical Issues
Sudden cardiac death echocardiography and ultrasound On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Sudden cardiac death echocardiography and ultrasound All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Sudden cardiac death echocardiography and ultrasound
CDC on Sudden cardiac death echocardiography and ultrasound
Sudden cardiac death echocardiography and ultrasound in the news
Blogs on Sudden cardiac death echocardiography and ultrasound
Directions to Hospitals Treating Sudden cardiac death
Risk calculators and risk factors for Sudden cardiac death echocardiography and ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Edzel Lorraine Co, DMD, MD [3]

Overview

Echocardiography may be helpful in the diagnosis the cause of lethal arrhythmia and sudden cardiac arrest by assessment of the following:

Class I (Level of Evidence: B)
Baseline familial evaluation of sudden arrhythmic death syndrome (SADS) decedents is recommended to include taking a medical history and performing physical examination, standard and high precordial lead ECG, echocardiography, and exercise testing.

Class I (Level of Evidence: C)
Coronary imaging and cardiac magnetic resonance (CMR) with late gadolinium enhancement (LGE) are recommended for evaluation of cardiac structure and function in all SCA survivors without a clear underlying cause.

Class I (Level of Evidence: B)
Echocardiography is recommended in patients with ventricular arrhythmia for evaluation of underlying structural heart disease

↑ Parker, Brian K.; Salerno, Alexis; Euerle, Brian D. (2018). "The Use of Transesophageal Echocardiography During Cardiac Arrest Resuscitation: A Literature Review". Journal of Ultrasound in Medicine. 38 (5): 1141–1151. doi:10.1002/jum.14794. ISSN 0278-4297.
↑ Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA; et al. (2022). "2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death". Eur Heart J. 43 (40): 3997–4126. doi:10.1093/eurheartj/ehac262. PMID 36017572 Check |pmid= value (help).
↑ Al-Khatib, Sana M.; Stevenson, William G.; Ackerman, Michael J.; Bryant, William J.; Callans, David J.; Curtis, Anne B.; Deal, Barbara J.; Dickfeld, Timm; Field, Michael E.; Fonarow, Gregg C.; Gillis, Anne M.; Granger, Christopher B.; Hammill, Stephen C.; Hlatky, Mark A.; Joglar, José A.; Kay, G. Neal; Matlock, Daniel D.; Myerburg, Robert J.; Page, Richard L. (2018). "2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death". Circulation. 138 (13). doi:10.1161/CIR.0000000000000549. ISSN 0009-7322.